Sanctuary Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Sanctuary Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-84	Closed	-$1.17K	–	305
2024 Q1	$1.17K	Hold	84	–	–	﹤0.01%	231
2023 Q4	$1.2K	Hold	84	–	–	﹤0.01%	234
2023 Q3	$1.3K	Hold	84	–	–	﹤0.01%	217
2023 Q2	$1.32K	Buy	+84	New	+$1.38K	﹤0.01%	228
2022 Q4	$1.31K	Buy	+84	New	+$1.17K	﹤0.01%	211

Other funds holding TAK

GAM

Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Sanctuary Wealth Management's TAK Position: Q2 2024 in Review

Sanctuary Wealth Management sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 84 shares — an estimated $1.17K sold.

Sanctuary Wealth Management first reported a position in TAK in Q4 2022 and held it in 5 quarters. The position peaked at $1.32K in Q2 2023. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

Sanctuary Wealth Management reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Sanctuary Wealth Management sold 84 Takeda Pharmaceutical shares in Q2 2024, an estimated $1.17K.
Sanctuary Wealth Management first reported a position in Takeda Pharmaceutical in Q4 2022 and held it in 5 quarters.
Sanctuary Wealth Management's Takeda Pharmaceutical position peaked at $1.32K in Q2 2023.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on Sanctuary Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.